• Explore /
  • Poster
  • / Olaparib maintenance monotherapy for non-germline BRCA1/2-mutated (non-gBRCAm) platinum-sensitive relapsed ovarian cancer (PSR OC) patients (pts): Phase IIIb OPINION primary analysis.

Olaparib maintenance monotherapy for non-germline BRCA1/2-mutated (non-gBRCAm) platinum-sensitive relapsed ovarian cancer (PSR OC) patients (pts): Phase IIIb OPINION primary analysis.

Abstract Video & Slides Poster

Authors

null

Andres Poveda

Initia Oncology, Valencia, Spain

Andres Poveda , Stephanie Lheureux , Nicoletta Colombo , David Cibula , Kristina Lindemann , Johanne I Weberpals , Maria Bjurberg , Ana Oaknin , Magdalena Sikorska , Antonio Gonzalez Martin , Radoslaw Madry , María Jesus Rubio , Jonathan A. Ledermann , Richard Davidson , Christopher Blakeley , James Bennett , Jessica Brown , Alan Barnicle , Erik Skof

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Ovarian Cancer

Clinical Trial Registration Number

NCT03402841

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 5545)

DOI

10.1200/JCO.2021.39.15_suppl.5545

Abstract #

5545

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Andres Poveda

First Author: Kirsten Timms

First Author: Karen Anne Cadoo

First Author: Jacob Korach